AU2021247584B2 - Sialic acid compositions for use in inhibiting and treating coronavirus infection - Google Patents

Sialic acid compositions for use in inhibiting and treating coronavirus infection Download PDF

Info

Publication number
AU2021247584B2
AU2021247584B2 AU2021247584A AU2021247584A AU2021247584B2 AU 2021247584 B2 AU2021247584 B2 AU 2021247584B2 AU 2021247584 A AU2021247584 A AU 2021247584A AU 2021247584 A AU2021247584 A AU 2021247584A AU 2021247584 B2 AU2021247584 B2 AU 2021247584B2
Authority
AU
Australia
Prior art keywords
sialic acid
nana
acid
cov
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021247584A
Other languages
English (en)
Other versions
AU2021247584A1 (en
Inventor
Jan Remmereit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifescience AS
Original Assignee
Lifescience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescience AS filed Critical Lifescience AS
Publication of AU2021247584A1 publication Critical patent/AU2021247584A1/en
Application granted granted Critical
Publication of AU2021247584B2 publication Critical patent/AU2021247584B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2021247584A 2020-04-01 2021-03-31 Sialic acid compositions for use in inhibiting and treating coronavirus infection Active AU2021247584B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003477P 2020-04-01 2020-04-01
US63/003,477 2020-04-01
PCT/IB2021/000200 WO2021198774A1 (en) 2020-04-01 2021-03-31 Sialic acid compositions for use in inhibiting and treating coronavirus infection

Publications (2)

Publication Number Publication Date
AU2021247584A1 AU2021247584A1 (en) 2022-10-20
AU2021247584B2 true AU2021247584B2 (en) 2023-11-02

Family

ID=76250375

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021247584A Active AU2021247584B2 (en) 2020-04-01 2021-03-31 Sialic acid compositions for use in inhibiting and treating coronavirus infection

Country Status (9)

Country Link
US (3) US11813271B2 (https=)
EP (1) EP4125926A1 (https=)
JP (1) JP2023520703A (https=)
KR (1) KR20220161413A (https=)
CN (1) CN115461057A (https=)
AU (1) AU2021247584B2 (https=)
BR (1) BR112022019685A2 (https=)
CA (1) CA3173633A1 (https=)
WO (1) WO2021198774A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230226088A1 (en) * 2020-06-09 2023-07-20 The Texas A&M University System Therapeutics for treatment of covid-19 symptoms
WO2023104402A1 (en) 2021-12-09 2023-06-15 Frieslandcampina Nederland B.V. Milk fraction that inhibits covid-19 infection

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019073298A1 (en) * 2017-10-11 2019-04-18 Lifescience As N-acetylneuraminic acid compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
EP2364139A2 (en) * 2008-11-10 2011-09-14 Life Science Nutrition AS Ngna compositions and methods of use
AU2010315024B2 (en) * 2009-11-06 2015-02-12 Nexbio, Inc. Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract
CN111481560A (zh) * 2020-04-23 2020-08-04 菌维他(北京)医疗科技有限公司 唾液酸及衍生物在制备防治冠状病毒疾病的药品中的应用
CN111658631A (zh) 2020-06-11 2020-09-15 广东盛普生命科技有限公司 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019073298A1 (en) * 2017-10-11 2019-04-18 Lifescience As N-acetylneuraminic acid compositions and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YANG YANG ET AL: "Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective", INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020), vol. 16, no. 10, pages 1708 - 1717 *

Also Published As

Publication number Publication date
US20260083762A1 (en) 2026-03-26
US20240148763A1 (en) 2024-05-09
KR20220161413A (ko) 2022-12-06
JP2023520703A (ja) 2023-05-18
WO2021198774A1 (en) 2021-10-07
AU2021247584A1 (en) 2022-10-20
BR112022019685A2 (pt) 2022-11-22
CA3173633A1 (en) 2021-10-07
EP4125926A1 (en) 2023-02-08
CN115461057A (zh) 2022-12-09
US11813271B2 (en) 2023-11-14
US12390481B2 (en) 2025-08-19
US20230128687A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
US20260083762A1 (en) Sialic acid compositions for the use of inhibiting and treating coronavirus infection
US11672814B2 (en) NGNA compositions and methods of use
AU2018349244B2 (en) N-acetylneuraminic acid compositions and methods of use
US20020006445A1 (en) Composition and method for treating the effects of diseases and maladies
US20020128273A1 (en) Composition and method for treating the effects of diseases and maladies
CA3030971A1 (en) Methods for treating cystic fibrosis and other diseases affecting mucosal surfaces
US20010044411A1 (en) Composition and method for treating the effects of diseases and maladies
US11752108B2 (en) Gold particles including an oleo-gum resin and/or a derivative thereof and methods of preparing and using the same
HK40084501A (en) Sialic acid compositions for use in inhibiting and treating coronavirus infection
CN115209954B (zh) 用于治疗呼吸系统病变的组合物
US20210077422A1 (en) Cannabinoid formulation including synergistic organosulphur compounds
US12403158B1 (en) Phytochemical/ nutraceutical composition for multimodal prophylaxis against and treatment of viral and bacterial infection and inflammation
RO138617A0 (ro) Compoziţie farmaceutică inovatoare sub formă de spray oral pentru sănătatea respiratorie
US20230233456A1 (en) Compositions and methods for treating coronavirus
US20260014198A1 (en) Antiviral Composition for Animals
EP4132484A1 (en) Composition comprising resveratrol
US20250134924A1 (en) Composition for Prevention and Treatment of Bacterial and Viral Infections and Inflammation
HK1050996A1 (en) Natural-phytotherapic composition based on hydroglyceric extracts for aerosol therapy
HK1050996B (en) Natural-phytotherapic composition based on hydroglyceric extracts for aerosol therapy

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)